
Join to view full profile
1700 S Tamiami TrlSarasota, FL 34239
Phone+1 941-330-1696
Fax+1 877-576-1434
Dr. Voelker is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Fellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
Orlando HealthResidency, Internal Medicine, 1989 - 1992
University of Florida College of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1992 - Present
FL State Medical License 1990 - 2028
American Board of Internal Medicine Critical Care Medicine
Clinical Trials
Publications & Presentations
PubMed
- 9 citationsPhase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with CO...F Linzee Mabrey, Hui Nian, Chang Yu, Elizabeth M Barnes, Uma Malhotra
Ebiomedicine. 2023-07-01 - 2 citationsEffectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 InfectionNatalia Lattanzio, Cristina Acosta-Diaz, Ricardo J Villasmil, Zachary Kirkland, Caitlin Bass
Cureus. 2021-07-30 - 127 citationsImproving lung function in severe heterogenous Emphysema with the Spiration Valve System (EMPROVE) a multicenter, open-label randomized controlled clinical trialGerard J. Criner, Antoine Delage, Kirk Voelker, D. Kyle Hogarth, Adnan Majid
American Journal of Respiratory and Critical Care Medicine. 2019-12-01
Journal Articles
- Improving Lung Function in Severe Heterogenous Emphysema with the Spiration® Valve System (EMPROVE): A Multicenter, Open-Label, Randomized, Controlled TrialG.J. Criner, A. Delage,Kirk Voelker, American Journal or Respiratory and Critical Care, 2/20/2019
- Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): Randomised, sham-controlled, multicentre trialPallav L Shah,Dirk-Jan Slebos, Kirk Voelker, Lancet, 9/2011
Press Mentions
Sarasota Memorial Hospital Starts Clinical Trial of COVID-19 TreatmentApril 15th, 2021- First COVID-19 Treatment Approved by FDA Studied Early on During Pandemic at Sarasota Memorial HospitalOctober 23rd, 2020
Sarasota Memorial Hospital Administers Same Antibody Cocktail Trump ReceivedOctober 7th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: